← back to search

Steven Knox

Gilead Sciences (United States) · US
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Medicine, Sofosbuvir, Internal medicine, Ledipasvir, Genotype, and Virology.
h-index
citations
630
works
6
NIH funding
primary concept
email

Recent publications

Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection
Journal of Hepatology 2022cited by 41position: middledoi
Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection
Journal of Hepatology 2022cited by 35position: middledoi
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China
Journal of Gastroenterology and Hepatology 2018cited by 17position: middledoi
NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome
Journal of Hepatology 2017cited by 202position: middledoi
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
Hepatology 2015cited by 256position: middledoi
Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older
Hepatology 2015cited by 79position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Masashi Mizokami · National Center for Global Health and Medicine3 papers (2015–2017)Alessandra Mangia · NIHR Birmingham Biomedical Research Centre3 papers (2015–2017)Stefan Zeuzem · Heidelberg University2 papers (2015–2017)Nezam H. Afdhal · Harvard University2 papers (2015–2015)Mark Sulkowski · Johns Hopkins Bayview Medical Center2 papers (2015–2017)John G. McHutchison · Gilead Sciences (United States)2 papers (2015–2017)Hadas Dvory‐Sobol · Medizinische Hochschule Hannover2 papers (2015–2017)Masao Omata · University of Yamanashi Hospital2 papers (2015–2015)William T. Symonds · Gilead Sciences (United States)1 papers (2015–2015)Jordan J. Feld · University Health Network1 papers (2015–2015)Gregory J. Dore · UNSW Sydney1 papers (2017–2017)Sarah H. Park · University of California, Los Angeles1 papers (2015–2015)Ed Eggleton · Gilead Sciences (United States)1 papers (2015–2015)Ross Martin · Gilead Sciences (United States)1 papers (2017–2017)Mani Subramanian · National Heart Lung and Blood Institute1 papers (2015–2015)Ira M. Jacobson · NYU Langone Health1 papers (2017–2017)Eric Lawitz · Indiana University – Purdue University Indianapolis1 papers (2015–2015)Stanislas Pol · Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale1 papers (2015–2015)Tania M. Welzel · Heidelberg University1 papers (2015–2015)Sammy Saab · UCLA Medical Center1 papers (2015–2015)